Secondary retensioning of a tether-based device for transapical transcatheter mitral valve implantation.

TMVI TMVR Tendyne mitral valve paravalvular leakage retensioning

Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
28 Dec 2023
Historique:
received: 12 07 2023
revised: 01 11 2023
accepted: 27 12 2023
medline: 28 12 2023
pubmed: 28 12 2023
entrez: 28 12 2023
Statut: aheadofprint

Résumé

Relevant paravalvular leakage (PVL) due to prothesis dislodgement is a rare but potentially severe complication after transcatheter mitral valve implantation (TMVI). Due to the epicardial anchoring mechanism of the Tendyne® TMVI-system, repositioning of the valve stent may be possible by retensioning of the tether. This multicentre-study aimed to investigate the procedural and short-term safety as well as efficacy of retensioning-maneuvers. From 2017 to 2021, N = 18 patients who underwent secondary tether-retensioning were identified. Baseline, procedural and follow-up data were available from N = 11 patients and analyzed according to the Mitral Valve Research Consortium (MVARC) definitions. Continuous variables are shown as median with interquartile range. All Patients [age 75 years (73.5, 85.0), 64% male (N = 7), EuroSCORE II 6.2% (5.8, 11.6)] presented with post-procedural PVL [63.6% (N = 7) with PVL ≥ 3+]. Of these, 54% (N = 6) showed signs of hemolysis. The majority were severely symptomatic [NYHA≥III (91%, N = 10)]. Procedural outcomes revealed no acute complications and no mortality. At discharge, PVL was completely eliminated in 91% (N = 10) of patients with one case of remaining moderate PVL. At 30 days, MVARC device success was achieved in 82% (N = 9) of patients. Two patients required open surgical mitral valve replacement due to persistent and recurrent PVL. In 89% (N = 8) of patients with successful retensioning procedure NYHA-class was I/II. There was no 30-day mortality. This multicentre-study demonstrates technical feasibility, procedural safety and acute efficacy of retensioning-procedures in the majority of patients. The potential to retension the tether in transapical TMVI may provide additional management advantages in populations at high surgical risk.

Identifiants

pubmed: 38152923
pii: 7502957
doi: 10.1093/ejcts/ezad430
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Martin Beyer (M)

Department of Cardiovascular Surgery, University Heart & Vascular Center Hamburg, Germany.

David Muller (D)

Cardiology Department, St Vincent's Hospital, Sydney, New South Wales, Australia.

Federico De Marco (F)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, Milan, Italy.

Vinay Badhwar (V)

Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, West Virginia.

Jean-Francois Obadia (JF)

Department of Cardiac Surgery, "Louis Pradel" Cardiologic Hospital, Lyon, France.

Fabien Praz (F)

Department of Cardiology, University Hospital Bern, University of Bern, Bern, Switzerland.

Thomas Modine (T)

Department of Cardiology and Cardiovascular Surgery, Heart Valve Center, Institut Cœur Poumon CHU de Bordeaux, France.

Pim Tonino (P)

Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands.

Gry Dahle (G)

Department of Cardiothoracic Surgery, Oslo University Hospital, Norway.

Alfredo Cerillo (A)

Department of Cardiac Surgery, Careggi University Hospital, Florence, Italy.

Sebastian Ludwig (S)

Department of Cardiology, University Heart & Vascular Center Hamburg, Hamburg, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg.

Lenard Conradi (L)

Department of Cardiovascular Surgery, University Heart & Vascular Center Hamburg, Germany.

Classifications MeSH